Surgical Innovations Group plc (AIM:SUN)
London
· Delayed Price · Currency is GBP · Price in GBX 0.6700
-0.0300 (-4.29%)
Jun 18, 2025, 1:14 PM GMT+1
AIM:SUN Revenue
In the year 2024, Surgical Innovations Group had annual revenue of 11.95M GBP, down -0.57%. Surgical Innovations Group had revenue of 5.77M in the half year ending December 31, 2024, a decrease of -2.65%.
Revenue
11.95M
Revenue Growth
-0.57%
P/S Ratio
0.55
Revenue / Employee
140.53K
Employees
85
Market Cap
6.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.95M | -69.00K | -0.57% |
| Dec 31, 2023 | 12.01M | 674.00K | 5.94% |
| Dec 31, 2022 | 11.34M | 2.21M | 24.26% |
| Dec 31, 2021 | 9.13M | 2.80M | 44.19% |
| Dec 31, 2020 | 6.33M | -4.40M | -41.03% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Surgical Innovations Group News
- 4 months ago - AIM Market Roundup: Gelion, Surgical Innovations, Deltex Medical - The Armchair Trader